No Data
No Data
RBC Raises Price Target on CG Oncology to $68 From $66, Keeps Outperform, Speculative Risk
CG Oncology Stock (CGON) Surges 25% As Cancer Drug Shows Remarkable Results
Top Midday Gainers
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
$CGON Stock Is up 31% Today. Here's What We See in Our Data.
CG Oncology Price Target Maintained With a $75.00/Share by Cantor Fitzgerald